These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 30918022)

  • 21. Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy.
    Al-Samkari H; Connors JM
    Blood Adv; 2019 Nov; 3(22):3770-3779. PubMed ID: 31770442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microparticles and cancer thrombosis in animal models.
    Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C
    Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice. An Observational Study in Routine Clinical Practice.
    den Exter PL; Hooijer J; van der Hulle T; van Oosten JP; Dekkers OM; Klok FA; Huisman MV
    Thromb Haemost; 2017 Nov; 117(11):2163-2167. PubMed ID: 28981552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematologic malignancies and thrombosis.
    Elice F; Rodeghiero F
    Thromb Res; 2012 Mar; 129(3):360-6. PubMed ID: 22197450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antithrombotic agents and invasive procedures--hematologist point of view.
    Lecompte TP
    Thromb Res; 2012 Oct; 130 Suppl 1():S61-2. PubMed ID: 23026666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study.
    Bauersachs R; Lee AYY; Kamphuisen PW; Meyer G; Janas MS; Jarner MF; Khorana AA;
    Thromb Haemost; 2018 May; 118(5):914-921. PubMed ID: 29618162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis.
    Giustozzi M; Agnelli G; Del Toro-Cervera J; Klok FA; Rosovsky RP; Martin AC; Herold J; Tzoran I; Szmit S; Bertoletti L; Becattini C; Huisman MV
    Thromb Haemost; 2020 Jul; 120(7):1128-1136. PubMed ID: 32365386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence.
    Jiménez-Fonseca P; Gallardo E; Arranz Arija F; Blanco JM; Callejo A; Lavin DC; Costa Rivas M; Mosquera J; Rodrigo A; Sánchez Morillas R; Vares Gonzaléz M; Muñoz A; Carmona-Bayonas A
    Eur J Intern Med; 2022 Jun; 100():33-45. PubMed ID: 35227541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of race and gender on antithrombotic therapy.
    Capodanno D; Angiolillo DJ
    Thromb Haemost; 2010 Sep; 104(3):471-84. PubMed ID: 20664898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Underlying Mechanisms of Thrombosis Associated with Cancer and Anticancer Therapies.
    Pantazi D; Alivertis D; Tselepis AD
    Curr Treat Options Oncol; 2024 Jul; 25(7):897-913. PubMed ID: 38862694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours.
    Chai-Adisaksopha C; Linkins LA; ALKindi SY; Cheah M; Crowther MA; Iorio A
    Thromb Haemost; 2017 Feb; 117(3):589-594. PubMed ID: 28078351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quick reference guide to the new oral anticoagulants.
    Hurst K; Lee R; Handa A
    J Vasc Surg; 2016 Jun; 63(6):1653-7. PubMed ID: 27113315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood coagulation and cancer: thrombosis and survival, clinical relevance and impact. An introduction.
    Vestjens JH; Sassen S; Prins MH
    Pathophysiol Haemost Thromb; 2008; 36(3-4):113-21. PubMed ID: 19176984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Network meta-analysis of anticoagulation strategies for venous thromboembolism in patients with cancer.
    Ueyama H; Miyashita H; Takagi H; Cruz C; Burger A; Briasoulis A; Kuno T
    J Thromb Thrombolysis; 2021 Jan; 51(1):102-111. PubMed ID: 32458316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stroke and Thromboprophylaxis in the Era of COVID-19.
    Ma A; Kase CS; Shoamanesh A; Abdalkader M; Pikula A; Sathya A; Catanese L; Ellis AT; Nguyen TN
    J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105392. PubMed ID: 33130478
    [No Abstract]   [Full Text] [Related]  

  • 37. Cancer related venous thromboembolism - prophylaxis and therapy.
    Gary T
    Vasa; 2014 Jul; 43(4):245-51. PubMed ID: 25007902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rivaroxaban: an oral factor Xa inhibitor.
    Thomas TF; Ganetsky V; Spinler SA
    Clin Ther; 2013 Jan; 35(1):4-27. PubMed ID: 23328267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticancer treatment and thrombosis.
    Falanga A; Marchetti M
    Thromb Res; 2012 Mar; 129(3):353-9. PubMed ID: 22119391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of cancer-associated venous thromboembolism - a case-based practical approach.
    Voigtlaender M; Langer F
    Vasa; 2018 Feb; 47(2):77-89. PubMed ID: 29325495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.